Literature DB >> 33644040

MiR-132-3p Modulates MEKK3-Dependent NF-κB and p38/JNK Signaling Pathways to Alleviate Spinal Cord Ischemia-Reperfusion Injury by Hindering M1 Polarization of Macrophages.

Hua Fang1,2,3, Hua-Feng Li4, Qin Pan1,2,3, Hon-Ling Jin1,2,3, Miao Yang1,2,3, Ru-Rong Wang5, Quan-Yun Wang5, Jian-Ping Zhang1,2,3.   

Abstract

Spinal cord ischemia-reperfusion (SCIR) injury is a serious complication of open surgical and endovascular aortic procedures. MicroRNA-132-3p (miR-132-3p) has been reported to be involved in the progression of various diseases, but its role in SCIR injury is unclear. Thus, we aimed in this study to investigate the mechanism of miR-132-3p in SCIR injury and explore its pathway as a therapeutic target for SCIR injury. We first constructed a SCIR injury rat model and documented motor function in the model. Reverse transcription quantitative polymerase chain reaction (RT-qPC)R and Western blot analysis were used to detect the expression of miR-132-3p and mitogen-activated protein kinase kinase kinase 3 (MEKK3) in SCIR injury rats. The interaction between miR-132-3p and MEKK3 was identified by dual-luciferase reporter gene assay. Then, the effects of miR-132-3p and MEKK3 on macrophage M1 polarization were evaluated in vitro and in vivo by altering their expression in macrophages of SCIR injury rats, with treatments altering the nuclear factor-kappaB (NF-κB) and c-Jun N-terminal kinase (JNK)/p38 signaling pathways using SP600125, SB203580, or PDTC. The SCIR injury rats had a high Tarlov score and low miR-132-3p expression along with high MEKK3 expression. miR-132-3p could directly bind to MEKK3, and that macrophage M1 polarization and inflammation could be inhibited by overexpression of miR-132-3p through downregulating MEKK3 and inactivating the NF-κB and p38/JNK signaling pathways. Besides, increased miR-132-3p expression could decrease the injured rat Tarlov score. Overall, our study demonstrated that miR-132-3p can suppress M1 polarization of macrophages and alleviate SCIR injury by blocking the MEKK3-dependent activation of the NF-κB and p38/JNK signaling pathway. Thus, miR-132-3p and its downstream pathways may be useful targets to alleviate the symptoms of SCIR injury.
Copyright © 2021 Fang, Li, Pan, Jin, Yang, Wang, Wang and Zhang.

Entities:  

Keywords:  MEKK3; NF-κB; macrophage; microRNA-132-3p; p38/JNK; spinal cord ischemia-reperfusion injury

Year:  2021        PMID: 33644040      PMCID: PMC7905026          DOI: 10.3389/fcell.2021.570451

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  42 in total

1.  Myocardial uptake and pharmacodynamics of quinidine and propafenone in isolated rabbit hearts: metabolic versus respiratory acidosis.

Authors:  A M Gillis; R Keashly
Journal:  J Cardiovasc Pharmacol       Date:  1991-04       Impact factor: 3.105

2.  RNAi silencing of the MEKK3 gene promotes TRAIL-induced apoptosis in MCF-7 cells and suppresses the transcriptional activity of NF-κB.

Authors:  Shan-Yu Guo; Shou-Gui Liu; Lei Liu; Xiao-Jian Zhou; Yan Gu
Journal:  Oncol Rep       Date:  2011-10-20       Impact factor: 3.906

Review 3.  Biophysical regulation of macrophages in health and disease.

Authors:  Vijaykumar S Meli; Praveen K Veerasubramanian; Hamza Atcha; Zachary Reitz; Timothy L Downing; Wendy F Liu
Journal:  J Leukoc Biol       Date:  2019-03-12       Impact factor: 4.962

4.  Responses of microRNAs 124a and 223 following spinal cord injury in mice.

Authors:  K Nakanishi; T Nakasa; N Tanaka; M Ishikawa; K Yamada; K Yamasaki; N Kamei; B Izumi; N Adachi; S Miyaki; H Asahara; M Ochi
Journal:  Spinal Cord       Date:  2009-07-21       Impact factor: 2.772

5.  MicroRNA dysregulation in the spinal cord following traumatic injury.

Authors:  Mónica Yunta; Manuel Nieto-Díaz; Francisco J Esteban; Marcos Caballero-López; Rosa Navarro-Ruíz; David Reigada; D Wolfgang Pita-Thomas; Angela del Águila; Teresa Muñoz-Galdeano; Rodrigo M Maza
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

6.  MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway.

Authors:  Xiao-Qian Li; Huang-Wei Lv; Zhi-Lin Wang; Wen-Fei Tan; Bo Fang; Hong Ma
Journal:  J Neuroinflammation       Date:  2015-02-07       Impact factor: 8.322

7.  Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats.

Authors:  Xiao-Qian Li; Huang-Wei Lv; Wen-Fei Tan; Bo Fang; He Wang; Hong Ma
Journal:  J Neuroinflammation       Date:  2014-03-28       Impact factor: 8.322

8.  MicroRNAs as potential therapeutics for treating spinal cord injury.

Authors:  Hualin Yan; Peiwei Hong; Mei Jiang; Hedong Li
Journal:  Neural Regen Res       Date:  2012-06-15       Impact factor: 5.135

9.  Ischemic preconditioning protects against spinal cord ischemia-reperfusion injury in rabbits by attenuating blood spinal cord barrier disruption.

Authors:  Bo Fang; Xiao-Man Li; Xi-Jia Sun; Na-Ren Bao; Xiao-Yan Ren; Huang-Wei Lv; Hong Ma
Journal:  Int J Mol Sci       Date:  2013-05-17       Impact factor: 5.923

10.  MicroRNA regulatory pattern in spinal cord ischemia-reperfusion injury.

Authors:  Zhi-Gang Liu; Yin Li; Jian-Hang Jiao; Hao Long; Zhuo-Yuan Xin; Xiao-Yu Yang
Journal:  Neural Regen Res       Date:  2020-11       Impact factor: 5.135

View more
  3 in total

1.  Berberine Attenuates Neonatal Sepsis in Mice By Inhibiting FOXA1 and NF-κB Signal Transduction Via the Induction of MiR-132-3p.

Authors:  Binghui Li; Shiping Niu; Hongli Geng; Changkun Yang; Changliang Zhao
Journal:  Inflammation       Date:  2021-09-14       Impact factor: 4.092

2.  miR-132-3p Modulates DUSP9-Dependent p38/JNK Signaling Pathways to Enhance Inflammation in the Amnion Leading to Labor.

Authors:  Zhuxia Zhong; Zezhang Liu; Rong Zheng; Jin Chai; Siwen Jiang
Journal:  Int J Mol Sci       Date:  2022-02-07       Impact factor: 5.923

3.  Exosomal miR-132-3p from mesenchymal stromal cells improves synaptic dysfunction and cognitive decline in vascular dementia.

Authors:  Xiaotang Ma; Yan Wang; Yumeng Shi; Suqing Li; Jinhua Liu; Xiangyong Li; Wangtao Zhong; Qunwen Pan
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.